Intracellular signaling pathways for norepinephrine- and endothelin-1-mediated regulation of myocardial cell apoptosis

Molecular and Cellular Biochemistry

Volumn 259, Issue 1-2, 2004, Pages 163-168

  Iwai Kanai, Eri ^a   Hasegawa, Koji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cardiac myocytes; Endothelin 1; Norepinephrine; Signaling pathways

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [[2 [[2 [[(HEXAHYDRO 1H AZEPIN 1 YL)CARBONYL]AMINO] 4 METHYLPENTANOYL]AMINO] 3 (1 METHYL 1H INDOL 3 YL)PROPIONYL]AMINO] 3 (2 PYRIDYL)PROPIONIC ACID; ALBUTANOL; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCINEURIN; CARVEDILOL; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLOSPORIN A; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; NEUROHORMONE; NORADRENALIN; PD 096859; PHENYLEPHRINE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; RAPAMYCIN; TACROLIMUS; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; UNINDEXED DRUG; WORTMANNIN; ZINC FINGER PROTEIN;

ADRENERGIC SYSTEM; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL PROTECTION; CELL SPECIFICITY; CELL SURVIVAL; CELL TYPE; DISEASE COURSE; HEART FAILURE; HEART MUSCLE CELL; HEART PROTECTION; HORMONAL REGULATION; INTRACELLULAR TRANSPORT; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; APOPTOSIS; DNA-BINDING PROTEINS; ENDOTHELIN-1; GATA4 TRANSCRIPTION FACTOR; MYOCYTES, CARDIAC; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS; PC12 CELLS; PHENYLPROPANOLAMINE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 1942503372     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:MCBI.0000021368.80389.b9     Document Type: Article

References (57)

1. Jacobson MD, Weil M, Raff MC: Programmed cell death in animal development. Cell 88: 347-354. 1997
2. Nagata S: Apoptosis by death factor. Cell 88: 355-365, 1997
3. Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Dec GW, Khaw BA: Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335: 1182-1189, 1996
4. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Natahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P: Apoptosis in the failing human heart. N Engl J Med 336: 1131-1141, 1997
5. Teiger E, Than VD, Richard L, Wisnewsky C, Tea BS, Gadoury L, Tremblay J, Schwartz K, Hamet P: Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest 97: 2891-2897, 1996
6. Li Z, Bing OH, Long X, Robinson KG, Lakatta EG: Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 272: H2313-H2319, 1997
7. Hirota H, Chen J, Bets UA, Rajewsky K, Gu Y, Ross J Jr, Muller W, Chien KR: Loss of gp 130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress. Cell 97: 189-198 1999
8. Francis GS, Chon JN, Johnson G, Rector TS, Goldman S, Simon A: Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II: The V-HeFT VA Cooperative Studies Group. Circulation 87(suppl VI): VI-40-VI-48, 1993
9. Packer M: The neurohormonal hypothesis: A theory to exolain the mechanism of disease progression in heart failure (editorial). J Am Coll Cardiol 20: 248-254, 1992
10. Wei CM, Lerman A, Rodeheffer RJ, McGregor CG, Brandt RR, Wright S, Heublein DM, Kao PC, Edwards WD, Burnett JC Jr: Endothelin in human congestive heart failure. Circulation 89: 1580-1586, 1994
11. Sakai S, Miyauchi T, Kobayashi M, Yamaguchi I, Goto K, Sugishita K: Inhibition of myocardial endothelin pathway improves long-term survival in heart failure. Nature 384: 353-355, 1996
12. Iwanaga Y, Kihara Y, Hasegawa K, Inagaki K, Yoneda T, Kaburagi S, Araki M, Sasayama S: Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation 98: 2065-2073, 1998
13. Hadcock JR, Malbon CC: Agonist regulation of gene expression of adrenergic receptors and G proteins. J Neurochem 60: 1-9, 1993
14. Rokosh DG, Stewart AF, Chang KC, Bailey BA, Karliner JS, Camacho SA, Long CS, Simpson PC: Alpha-adrenergic receptor subtype mRNAs are differentially regulated by alpha1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of alpha1B and alpha1D but induction of alpha1C. J Biol Chem 271: 5839-5843, 1996
15. Singh K, Xiao L, Remondino A, Sawyer DB, Colucci WS: Adrenergic regulation of cardiac myocyte apoptosis. J Cell Physiol 189: 257-265, 2001
16. Hasegawa K, Iwai-Kanai E, Sasayama S: Neurohormonal regulation of myocardial cell apoptosis during development of heart failure. J Cell Physiol 186: 11-18, 2001
17. Daaka Y, Luttrell LM, Lefkowitz RJ: Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A. Nature 390: 88-91, 1997
18. Iwai-Kanai E, Hasegawa K, Araki M, Kakita T, Morimoto T, Sasayama S: Alpha- and beta- adrenergic pathways differentially regulate cell type specific apoptosis in rat cardiac myocytes. Circulation 100: 305-311, 1999
19. Communal C, Singh K, Pimentel DR, Colucci WS: Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 98: 1329-1334, 1998
20. Engelhardt S, Hein L, Wiesmann F, Lohse MJ: Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA 96: 7059-7064, 1999
21. Iwase M, Bishop SP, Uechi M, Vatner DE, Shannon RP, Kudej RK, Wright DC, Wagner TE, Ishikawa Y, Homey CJ, Vatner SF: Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. Circ Res 78: 517-524, 1996
22. Shizukuda Y, Buttrick PM: Subtype specific roles of beta-adrenergic receptors in apoptosis of adult rat ventricular myocytes. J Mol Cell Cardiol 34: 823-831, 2002
23. Zaugg M, Xu W, Lucchinetti E, Shafiq SA, Jamali NZ, Siddiqui MA: Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes. Circulation 102: 344-350, 2000
24. Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ, Yue TL: Inhibition of p38 mitogen-activated protein kinase decreases and cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 99: 1685-1691, 1999
25. Yue TL, Ma XL, Wong X et al.: Possible involvement of stress-activated protein kinase signaling pathway and FAS receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol. Circ Res 82: 166-179, 1998
26. Packer M, Colucci WS, Sackner-Bernstein J et al.: Double blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE trial. Circulation 94: 2793-2799, 1996
27. Australia/New Zealand Heart Failure Collaborative Group: Randomized, placebo controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet 349: 375-380, 1997
28. Simpson P: Norepinephrine-stimulated hypertrophy of cultured rat myocardial cells is an alpha1 adrenergic response. J Clin Invest 72: 732-738, 1983
29. Akhter SA, Milano CA, Shotwell KF, Cho MC, Rockman HA, Lefkowitz RJ, Koch WJ: Transgenic mice with cardiac overexpression of alpha1 B-adrenergic receptors. In vivo alpha1 -adrenergic receptor-mediated regulation of beta-adrenergic signaling. J Biol Chem 272: 21253-21259, 1997
30. Grupp IL, Lorenz JN, Walsh RA, Boivin GP, Rindt H: Overexpression of alpha1 B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy. Am J Physiol 275: H1338-H1350, 1998
31. Hunter JJ, Chien KR: Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 341: 1276-1283, 1999
32. Iwai-Kanai E, Hasegawa K, Fujita M, Araki M, Yanazume T, Adachi S, Sasayama S: Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. J Cell Physiol 190: 54062, 2002
33. Bueno OF, Molkentin JD: Involvement of extracellular signal-regulated kinases in cardiac hypertrophy and cell death. Circ Res 91: 776-781, 2002
34. D'angelo DD, Sakata Y, Lorena JN, Boivin GP, Walsh GP, Liggett SB, Dorn GWI: Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 94: 8121-8126, 1997
35. Adams JW, Sakata Y, Davis MG, Sah VP, Wang Y, Liggett SB, Chien KR, Brown JH, Dorn GW: Enhanced Gαq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure. Proc Natl Acad Sci USA 95: 10140-10145, 1998
36. Sabri A, Wilson BA, Steinberg SF: Dual actions of the Gαq agonist Pasteurella multicoda toxin to promote cardiomyocyte, hypertrophy and enhance apoptosis susceptibility. Circ Res 90: 850-857, 2002
37. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M. Mitsui Y, Yazaki Y, Goto K, Masaki Y: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988
38. Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Muruno F, Hiroe M: Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 92: 398-403, 1993
39. Arai H, Hori S, Aramori I, Okubo H, Nakanishi S: Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732. 1990
40. Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, Masaki T: Cloning of a cDNA encoding a non-isopeptide-selective subtype of endothelin receptor. Nature 348: 732-735, 1990
41. Araki M, Hasegawa K, Iwai-Kanai E, Fujita M, Sawamura T, Kakita T, Wada H, Morimoto T, Sasayama S: Endothelin-1 as a protective factor against beta-adrenergic agonist-induced apoptosis in cardiac myocytes. J Am Coll Cardiol 36: 1411-1418, 2000
42. Pullen N, Dennis PB, Andjelkovic M, Dufner A, Kozma SC, Hemmings BA, Thomas G: Phosphorylation sites in the autoinhibitory domain participate in p70 (S6K) activation loop phosphorylation. Science 279: 707-710, 1998
43. Burnett PE, Barrow RK, Cohen N, Snyder SH, Sabatini DM: RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci 95: 1432-1437, 1998
44. Pearson RB, Dennis PB, Han JW, Williamson NA, Kozma SC, Wettenhall REH, Thomas G: The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J 21: 5279-5287, 1995
45. Ankersmit HJ, Roth G, Zuckermann A, Moser B, Obermaier R, Taghavi S, Brunner M, Wieselthaler G, Lanzenberger M, Ullrich R, Laufer G. Grimm M, Wolner E: Rapamycin as rescue therapy in a patient supported by biventricular assist device to heart transplantation with consecutive ongoing rejection. Am J Transplant 3: 231-234, 2003
46. Wang L, Gout I, Proud CG: Cross-talk between the ERK and p70 S6 kinase (S6K) signaling pathways. J Biol Chem 276: 32670-32677, 2001
47. Kakita T, Hasegawa K, Iwai-Kanai E, Adachi S, Morimoto T, Wada H, Kawamura T, Yanazume T, Sasayama S: Calcineurin pathway is required for endothelin-1-mediated protection against oxidant stress-induced apoptosis in cardiac myocytes. Circ Res 88: 1239-1246, 2001
48. Klee CB, Ren H, Wang X: Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem 273: 13367-13370, 1998
49. Wu H, Naya FJ, McKinsey TA, Mercer B, Shelton JM, Chin ER, Simard AR, Michel RN, Bassel-Duby R, Olsen EN, Williams, RS: MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J 19: 1963-1973, 2000
50. Vega RB, Yang J, Rothermel BA, Bassel-Duby R, Williams RS: Multiple domains of MCIP1 contribute to inhibition of calcineurin activity. J Biol Chem 277: 30401-30407, 2002
51. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN: A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93: 215-228, 1998
52. Saito S, Hiroi Y, Zou Y, Aikawa R, Toko H, Shibasaki F, Yazaki Y, Nagai R, Komuro, I: β-adrenergic pathway induces apoptosis through calcineurin activation in cardiac myocytes. J Biol Chem 275: 34528-34533, 2000
53. Lotem J, Kama R, Sachs L: Suppression or induction of apoptosis by opposing pathways downstream from calcium-activated calcineurin. Proc Natl Acad Sci USA 96: 12016-12020, 1999
54. Gill C, Mestril R, Samali A: Losing heart: The role of apoptosis in heart disease - a novel therapeutic target? FASEB J 16: 135-146, 2002
55. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD: The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19: 6341-6350, 2000
56. De Windt LJ, Lim HW, Taigen T, Wencker D, Condorelli G, Dorn GW, Kitsis RN, Molkentin JD: Calcineurin-mediated hypertrophy protects cardiomyocytes from apoptosis in vitro and in vivo: An apoptosis-independent model of dilated heart failure. Circ Res 18;86: 255-263, 2000
57. Feuerstein GZ, Young PR: Apoptosis in cardiac diseases: Stress- and mitogen-activated signaling. Cardiovasc Res 45: 560-569, 2000